670 related articles for article (PubMed ID: 16532439)
61. The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.
Nucifora G; Begy CR; Erickson P; Drabkin HA; Rowley JD
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7784-8. PubMed ID: 8395054
[TBL] [Abstract][Full Text] [Related]
62. Expression of the novel NUP98/PSIP1 fusion transcripts in myelodysplastic syndrome with t(9;11)(p22;p15).
Yamamoto K; Nakamachi Y; Yakushijin K; Funakoshi Y; Okamura A; Kawano S; Matsuoka H; Minami H
Eur J Haematol; 2012 Mar; 88(3):244-8. PubMed ID: 22103895
[TBL] [Abstract][Full Text] [Related]
63. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells.
Kurokawa M; Mitani K; Imai Y; Ogawa S; Yazaki Y; Hirai H
Blood; 1998 Dec; 92(11):4003-12. PubMed ID: 9834202
[TBL] [Abstract][Full Text] [Related]
64. Role of the RUNX1-EVI1 fusion gene in leukemogenesis.
Maki K; Yamagata T; Mitani K
Cancer Sci; 2008 Oct; 99(10):1878-83. PubMed ID: 19016745
[TBL] [Abstract][Full Text] [Related]
65. Expression of the TEL/EVI1 fusion transcript in a patient with chronic myelogenous leukemia with t(3;12)(q26;p13).
Nakamura Y; Nakazato H; Sato Y; Furusawa S; Mitani K
Am J Hematol; 2002 Jan; 69(1):80-2. PubMed ID: 11835339
[TBL] [Abstract][Full Text] [Related]
66. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.
Tang G; Hu S; Wang SA; Xie W; Lin P; Xu J; Toruner G; Zhao M; Gu J; Doty M; Li S; Medeiros LJ; Tang Z
J Mol Diagn; 2019 Mar; 21(2):343-351. PubMed ID: 30576868
[TBL] [Abstract][Full Text] [Related]
67. 3q26/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: An early event associated with a poor prognosis.
Hu Z; Hu S; Ji C; Tang Z; Thakral B; Loghavi S; Medeiros LJ; Wang W
Leuk Res; 2018 Feb; 65():25-28. PubMed ID: 29288910
[TBL] [Abstract][Full Text] [Related]
68. [Two cases of acute myeloid leukemia with t(16;21)(p11;q22) and TLS/FUS-ERG fusion transcripts].
Chang WR; Park IJ; Lee HW; Park JS; Kim HC; Kim HJ; Han JH; Cho SR
Korean J Lab Med; 2009 Oct; 29(5):390-5. PubMed ID: 19893346
[TBL] [Abstract][Full Text] [Related]
69. The AML1/ETO(MTG8) and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta) in the nucleus more efficiently than wild-type AML1.
Tanaka K; Tanaka T; Kurokawa M; Imai Y; Ogawa S; Mitani K; Yazaki Y; Hirai H
Blood; 1998 Mar; 91(5):1688-99. PubMed ID: 9473235
[TBL] [Abstract][Full Text] [Related]
70. Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML.
Mitterbauer M; Kusec R; Schwarzinger I; Haas OA; Lechner K; Jaeger U
Ann Hematol; 1998; 76(3-4):139-43. PubMed ID: 9619731
[TBL] [Abstract][Full Text] [Related]
71. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.
Kong XT; Ida K; Ichikawa H; Shimizu K; Ohki M; Maseki N; Kaneko Y; Sako M; Kobayashi Y; Tojou A; Miura I; Kakuda H; Funabiki T; Horibe K; Hamaguchi H; Akiyama Y; Bessho F; Yanagisawa M; Hayashi Y
Blood; 1997 Aug; 90(3):1192-9. PubMed ID: 9242552
[TBL] [Abstract][Full Text] [Related]
72. Translocation t(2;3)(p15-23;q26-27) in myeloid malignancies: report of 21 new cases, clinical, cytogenetic and molecular genetic features.
Stevens-Kroef M; Poppe B; van Zelderen-Bhola S; van den Berg E; van der Blij-Philipsen M; Geurts van Kessel A; Slater R; Hamers G; Michaux L; Speleman F; Hagemeijer A
Leukemia; 2004 Jun; 18(6):1108-14. PubMed ID: 15085164
[TBL] [Abstract][Full Text] [Related]
73. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression.
Ohyashiki JH; Ohyashiki K; Shimamoto T; Kawakubo K; Fujimura T; Nakazawa S; Toyama K
Blood; 1995 Jun; 85(12):3713-8. PubMed ID: 7780155
[TBL] [Abstract][Full Text] [Related]
74. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
Wang HY; Rashidi HH
Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
[TBL] [Abstract][Full Text] [Related]
75. Characterization of bone marrow mast cells in acute myeloid leukemia with t(8;21) (q22;q22); RUNX1-RUNX1T1.
Pullarkat ST; Pullarkat V; Lagoo A; Brynes R; Weiss LM; Bedell V; Chen W; Huang Q; Gaal K; Weisenburger DD; Kim YS
Leuk Res; 2013 Nov; 37(11):1572-5. PubMed ID: 24035334
[TBL] [Abstract][Full Text] [Related]
76. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histologic classification of chronic myeloproliferative disorders.
Werner M; Nolte M; Kaloutsi V; Buhr T; Kausche F; Georgii A
Lab Invest; 1995 Apr; 72(4):405-10. PubMed ID: 7723278
[TBL] [Abstract][Full Text] [Related]
77. Transcriptome sequencing reveals CHD1 as a novel fusion partner of RUNX1 in acute myeloid leukemia with t(5;21)(q21;q22).
Yao H; Pan J; Wu C; Shen H; Xie J; Wang Q; Wen L; Wang Q; Ma L; Wu L; Ping N; Zhao Y; Sun A; Chen S
Mol Cancer; 2015 Apr; 14():81. PubMed ID: 25879624
[TBL] [Abstract][Full Text] [Related]
78. Fusion of AML1/Runx1 to copine VIII, a novel member of the copine family, in an aggressive acute myelogenous leukemia with t(12;21) translocation.
Ramsey H; Zhang DE; Richkind K; Burcoglu-O'Ral A; Hromas R
Leukemia; 2003 Aug; 17(8):1665-6. PubMed ID: 12886257
[No Abstract] [Full Text] [Related]
79. Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia.
Kondo M; Kudo K; Kimura H; Inaba J; Kato K; Kojima S; Matsuyama T; Horibe K
Leuk Res; 2000 Nov; 24(11):951-6. PubMed ID: 11086178
[TBL] [Abstract][Full Text] [Related]
80. [Acute myeloid leukemia with t (3;8) (q26.2;q24), a simple variant of 3q26.2/EVI1 translocation].
Sato K; Sakai H; Uchida A; Uemura Y; Tsuruoka Y; Yokoi S; Nishio Y; Matsunawa M; Suzuki Y; Isobe Y; Kato M; Tomita N; Inoue Y; Miura I
Rinsho Ketsueki; 2017; 58(4):315-322. PubMed ID: 28484159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]